BioLab 612 LLC
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis (NCT02778763) | BioLab 612 LLC | 2015-12-01 |
| Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer (NCT02715882) | BioLab 612 LLC | 2015-11-01 |
Track BioLab 612 LLC automatically
Every clearance here is in the API, with alerts when new ones post.